A tosylate salt of Sorafenib which is a kinase inhibitor drug. It is used for the treatment of kidney, liver and thyroid cancer. It works by inhibiting the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. Reference standards of Sorafenib Tosylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
4-(4-Aminophenoxy)-N-methylpyridine-2-carboxamide
Catalogue No.:PA 46 17520
CAS :
Molecular Formula : C13H13N3O2
Molecular Weight : 243.26
4-[4-(Formylamino)phenoxy]-N-methylpyridine-2-carboxamide
Catalogue No.:PA 46 17530
Molecular Formula : C14H13N3O3
Molecular Weight : 271.27
4-Chloro-3-(trifluoromethyl)aniline
Catalogue No.:PA 46 17540
Molecular Formula : C7H5ClF3N
Molecular Weight : 195.57
Propan-2-yl [4-[[2-(methylcarbamoyl)pyridin-4-yl]oxy]phenyl]carbamate
Catalogue No.:PA 46 17550
Molecular Formula : C17H19N3O4
Molecular Weight : 329.35
4,4′-[Carbonylbis(iminobenzene-4,1-diyloxy)]bis(N-methylpyridine-2-carboxamide)
Catalogue No.:PA 46 17560
Molecular Formula : C27H24N6O5
Molecular Weight : 512.52
N-Methyl-4-[4-[[[3-(trifluoromethyl)phenyl]carbamoyl]amino]phenoxy]pyridine-2-carboxamide
Catalogue No.:PA 46 17570
Molecular Formula : C21H17F3N4O3
Molecular Weight : 430.38
Sorafenib Tosilate
Catalogue No.:PA 19 69000
Molecular Formula : C28H24ClF3N4O6S
Molecular Weight : 637.03
4-[4-[[[2-Chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino]phenoxy]-N-methylpyridine-2-carboxamide
Catalogue No.:PA 19 69530
Molecular Formula : C21H16ClF3N4O3
Molecular Weight : 464.82
Ethyl [4-chloro-3-(trifluoromethyl)phenyl]carbamate
Catalogue No.:PA 46 17070
Molecular Formula : C10H9ClF3NO2
Molecular Weight : 267.63
4-[4-[[[2-Chloro-3-(trifluoromethyl)phenyl]carbamoyl]amino]phenoxy]-N-methylpyridine-2-carboxamide Tosylate
Catalogue No.:PA 46 0170081
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
